Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21990e4d31a7d9a8141af7239fc11ca6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ce097fd1b099f02f34d6d2a8f57dc4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c3e6551a9176ad7baa01795aaf4eb88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ee59478d04e5e8d95f0ecb10137fd00 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-252 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
filingDate |
2004-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b08bcd391c56dc4fb46c4ed38205c81a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc1d2f68beeca36b88fb68be50fc6fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_884c750d09bf160af73a2306c243a761 |
publicationDate |
2005-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005039629-A2 |
titleOfInvention |
Caspase inhibitors as coating materiel for medical products for inhibiting restenosis |
abstract |
The present invention relates to a pharmaceutical composition comprising a caspase inhibitor and/or a compound of the general formula R-Lys-X, methods for coating medical products using said caspase inhibitors and/or said compounds of general formula R-Lys-X and medical products coated with said caspase inhibitors and/or said compounds of general formula R-Lys-X, wherein the coating inhibits restenosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501824-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7939505-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9339461-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9731016-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877729-B2 |
priorityDate |
2003-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |